v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common shares
Additional Paid-in Capital
(Accumulated Deficit) Retained Earnings
Noncontrolling Interest
Total
Balance, at Beginning of period at Dec. 31, 2024 $ 242 $ 105,207 $ 2,644   $ 108,093
Balance, at Beginning of period (in shares) at Dec. 31, 2024 24,173,209        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation   396     396
Dividends     (2,901)   (2,901)
Net income (loss)     1,249   1,249
Balance, at End of period at Mar. 31, 2025 $ 242 105,603 992   106,837
Balance, at End of period (in shares) at Mar. 31, 2025 24,173,209        
Balance, at Beginning of period at Dec. 31, 2025 $ 244 106,882 (2,752)   104,374
Balance, at Beginning of period (in shares) at Dec. 31, 2025 24,375,209        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation $ 1 1,191     1,192
Stock-based compensation (in shares) 150,000        
Issuance of stock, net of issuance costs $ 25 11,630     11,655
Issuance of stock, net of issuance costs (in shares) 2,520,206        
Contribution to JV   (800)   $ 800  
Common stock issued for vested restricted stock units $ 1 (1)      
Common stock issued for vested restricted stock units (in shares) 140,000        
Dividends     (783)   $ (783)
Stock options exercised $ 1 (1)      
Stock options exercised (in shares) 4,113       4,113
Net income (loss)     (1,630) (291) $ (1,921)
Balance, at End of period at Mar. 31, 2026 $ 272 $ 118,901 $ (5,165) $ 509 $ 114,517
Balance, at End of period (in shares) at Mar. 31, 2026 27,189,528